Skip to main content

Praxis Precision Medicines, Inc.

PRAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001689548

No open-market purchases or sales by Praxis Precision Medicines, Inc. insiders were filed in the last 90 days; 309 institutions reported holding it in 13F filings for Q2 2026, worth $11.3B in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Praxis Precision Medicines, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of PRAX: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders6880+12
Shares36.6M41.2M+4.54M (+12.4%)
Value$1.19B$751.0M−$437.3M (−36.8%)

New holders (24)

Institutions that held Praxis Precision Medicines, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to PRAX in Q2 2021
InstitutionSharesValue% of portfolio
PFM Health Sciences, LP455,374$8.32M0.27%
Kingdon Capital Management, L.L.C.250,000$4.57M0.70%
Endurant Capital Management LP199,565$3.65M1.00%
Marshall Wace, LLP188,836$3.45M0.02%
Two Sigma Investments, LP184,292$3.37M0.01%
Raymond James & Associates116,323$2.13M0.00%
Monashee Investment Management LLC100,000$1.83M0.22%
Sphera Funds Management Ltd.75,600$1.38M0.13%
Alyeska Investment Group, L.P.75,000$1.37M0.02%
Alps Advisors Inc57,455$1.05M0.01%
Swiss National Bank48,000$877.0K0.00%
D. E. Shaw & Co., Inc.45,264$827.0K0.00%
Voloridge Investment Management, LLC43,304$792.0K0.01%
Renaissance Technologies LLC37,400$684.0K0.00%
State of Wisconsin Investment Board31,500$576.0K0.00%
Alta Wealth Advisors LLC31,028$567.0K0.42%
Two Sigma Advisers, LP24,100$441.0K0.00%
Squarepoint Ops LLC17,427$319.0K0.00%
Credit Suisse AG10,826$197.0K0.00%
Virtus ETF Advisers LLC10,801$197.0K0.08%
O'Shaughnessy Asset Management, LLC1,004$18.0K0.00%
Rockefeller Capital Management L.P.400$7.00K0.00%
US Bancorp180$3.00K0.00%
Parallel Advisors, LLC47$1.00K0.00%

Sold out (12)

Institutions that held Praxis Precision Medicines, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.